Fundz

Heartflow, Leader In Revolutionizing Precision Heart Care, Closes $215 Million In Series F Funding Led By Bain Capital Life Sciences

PUBLIC · HTFLApr 06, 2023

Amount Raised

$215 Million

Round Type

Series F

Mountain ViewBiotechnologyHealth CareArtificial Intelligence

Description

HeartFlow, Inc., the leader in revolutionizing precision heart care, today announced the close of a $215 million Series F funding round by its parent company HeartFlow Holding, Inc., led by Bain Capital Life Sciences with participation from new investor Janus Henderson Investors, and existing investors including Baillie Gifford, Capricorn Investment Group, Hayfin Capital Management, HealthCor, Martis Capital, USVP and Wellington Management. This new funding will enable HeartFlow to meet the growing demand for its commercial products, support a robust body of growing clinical evidence and advance its comprehensive product portfolio to help physicians to diagnose coronary artery disease (CAD) and guide their treatment decisions.

Quick answer

Heartflow, Inc. raised $215 Million in a Series F round, dated April 6, 2023. Heartflow, Inc. is based in Mountain View, California, United States.

How much did Heartflow, Inc. raise?
Heartflow, Inc. raised $215 Million in a Series F round on April 6, 2023.
What does Heartflow, Inc. do?
HeartFlow is a medical technology company transforming the way cardiovascular disease is diagnosed and treated.
Where is Heartflow, Inc. based and how big is it?
Heartflow, Inc. is based in Mountain View, California, United States. Fundz records about 500 employees.
Who are the decision-makers at Heartflow, Inc?
Fundz holds 1 contact at Heartflow, Inc., including the Executive Officer, Director. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology and Health Care around the same time

Companies in the same sectors as Heartflow, Inc. that raised within 45 days of this round, from Fundz verified event records.

  • Lucem Health raised an undisclosed amount (Series A) on May 9, 2023.
  • Lucem Health raised $5.2M on April 28, 2023.
  • Mediwhale raised $9M (Funding Round) on April 18, 2023.
  • Persist AI raised $4.9M (Seed) on April 13, 2023.
  • Autonomize raised $4M (Seed) on March 27, 2023.
  • Health Plix raised $22M (Funding Round) on March 15, 2023.

Who to call at Heartflow, Inc., and when

A new round usually means Heartflow, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Heartflow, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Heartflow, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Heartflow, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Heartflow, Inc.

Location

1400B SEAPORT BLVD

Mountain View, California, United States

About

HeartFlow is a medical technology company transforming the way cardiovascular disease is diagnosed and treated. With our HeartFlow Analysis, a non-invasive personalized cardiac test, physicians are able to make better care decisions for their patients with suspected coronary artery disease--the number one killer of men and women worldwide. HeartFlow is backed by decades of scientific research and development and leverages the latest advancements in technology to help set a new standard of care for diagnosing cardiovascular care worldwide. Cleared for use in the United States, Canada, Europe and Japan and with offices in Redwood City, Austin, London and Japan, HeartFlow’s footprint is growing rapidly. HeartFlow has received more than $240 million dollars in funding in a recent Series E financing round, is pre-IPO and leverages the latest technology including deep learning and computational fluid dynamics. We try to embody the best of both technology and healthcare companies and hire people who are passionate about living our mission to save lives, improve the patient experience and reduce the overall cost of care.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Heartflow, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsVikram V., Executive Officer, DirectorSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Heartflow, Inc.'s next move

See what Strategic adds

Heartflow, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.